Close

Delmar Pharma (DMPI) Announces Presentation of Positive VAL-083 Data as Ovarian Cancer Treatment

Go back to Delmar Pharma (DMPI) Announces Presentation of Positive VAL-083 Data as Ovarian Cancer Treatment